2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
2019 ESC Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD
Publications
7 shownCardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Among patients receiving recommended therapy for heart failure, those in the empagliflozin group had a lower risk of cardiovascular death or hospitalization for heart failure th...
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Empagliflozin reduced the combined risk of cardiovascular death or hospitalization for heart failure in patients with heart failure and a preserved ejection fraction, regardless...
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
International audience
2016 European Guidelines on cardiovascular disease prevention in clinical practice
The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at \nthe t...
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
UK Medical Research Council, British Heart Foundation, National Institute for Health Research, US National Institutes of Health.
Frequent Co-Authors
Researcher Info
- h-index
- 7
- Publications
- 7
- Citations
- 27,917
- Institution
- University of Glasgow
External Links
Identifiers
- ORCID
- 0000-0002-1604-2593
Impact Metrics
h-index
7
h-index: Number of publications with at least h citations each.